CFO transition
Petros Pharmaceuticals, Inc. CFO transition: Robert Weinstein to succeed Mitchell Arnold
Petros Pharmaceuticals, Inc. reported in a Form 8-K filed June 18, 2026 that Robert Weinstein will succeed Mitchell Arnold as Chief Accounting Officer, Principal Financial Officer and Principal Accounting Officer, effective June 18, 2026.
In the filing's words
On June 18, 2026, the board of directors (the “Board”) of the Company appointed Robert Weinstein to the positions of Chief Accounting Officer, Principal Financial Officer and Principal Accounting Officer of the Company, effective immediately.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Petros Pharmaceuticals, Inc. (PTPI) |
|---|---|
| Event | Transition |
| Incoming | Robert Weinstein |
| Outgoing | Mitchell Arnold |
| Title in the filing | Chief Accounting Officer, Principal Financial Officer and Principal Accounting Officer |
| Effective | June 18, 2026 |
| 8-K filed | June 18, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Chief Financial Officer, TAO Synergies Inc. |
| SEC CIK | 0001815903 |
Petros Pharmaceuticals, Inc. reported this change in a Form 8-K, Item 5.02, filed June 18, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Robert Weinstein? Send a correction with the primary source.